Paper - WANFANG MED ONLINE

You Position: Home > Paper

Therapeutic efficacy and safety of hydroxychloroquine in treatment of osteoarthritis: A Meta-analysis

( views:0, downloads:0 )

Author:: No author available

Journal Title:: Chinese Journal of Biomedical Engineering

Issue:: 5

DOI:: 10.3760/cma.j.cn115668-20220325-00068

Key Word:: 羟氯喹;骨关节炎;随机对照试验;Meta分析;Hydroxychloroquine;Osteoarthritis;Randomized controlled trial;Meta-analysis

Abstract： Objective:To elucidate the efficacy of hydroxychloroquine (HCQ) in osteoarthritis (OA) via a Meta-analysis of randomized controlled trials (RCTs) .Methods:We used "hydroxychloroquine" and "osteoarthritis" as keywords for literature search in related databases. Only RCTs were included. The therapeutic efficacy and safety of HCQ were compared among the OA patients. A Meta-analysis with random-effect model was performed to assess the pain and function scales in the patients. Revman 5.3 software was used for Mmeta-analysis of the literature included.Results:Five RCT studies were finally included, comprising a total of 528 OA patients. The length of follow-up was 3 to 24 months. As shown by the Meta-analysis, the Western Ontario and McMaster Universities Arthritis Index (WOMAC) in 149 patients on HCQ [ SMD=0.10, 95% CI (-0.69, 0.89) , I2=0.85] and visual analogue score (VAS) of pain in 106 patients on HCQ [ SMD=0.02, 95%CI (-2.69, 2.73) , I2=0.00 ] were not statistically different compared with the control group. There was no statistical difference in adverse reactions between the two groups. Conclusion:The therapeutic efficacy and pain-relieving effect of hydroxychloroquine as a treatment of osteoarthritis differ across studies, rendering further research needed.

Reference

[1]曾惠琼,张跃,叶志中.骨关节炎相关自噬信号通路新知[J].2018,(10).
[2]Hu, Peng-Fei,Chen, Wei-Ping,Bao, Jia-Peng,etc.Paeoniflorin inhibits IL-1 beta-induced chondrocyte apoptosis by regulating the Bax/Bcl-2/caspase-3 signaling pathway[J].2018,17(4 Pt.B).
[3]Nathalie, Costedoat-Chalumeau,Bertrand, Dunogué,Nathalie, Morel,etc.Hydroxychloroquine: a multifaceted treatment in lupus.[J].2014,43(6 Pt 2).
[4]Hyun Sook, Hwang,Hyun Ah, Kim.Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis.[J].2015,16.
[5]Detert Jacqueline,Klaus Pascal,Listing Joachim,etc.Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial[J].2014,15(1).
[6].Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline[J].2018,10(4).
[7]Ye Zhi-Zhong,Zhang Zhi-Yi,Li Zhan-Guo,etc.Toward wiping out osteoarthritis in China: research highlights[J].2020,133(8).
[8]Saviola,G.,Abdi-Ali,L.,Campostrini,L.,etc.Clodronate and hydroxychloroquine in erosive osteoarthritis: A 24-month open randomized pilot study[J].2012,22(2).
[9]Burr,D.B.,Gallant,M.A..Bone remodelling in osteoarthritis[J].2012,8(11).
[10]Pradeep Kumar,Sacitharan.Ageing and Osteoarthritis.[J].2019,91.
[11]Chevalier, X.,Ravaud, P.,Maheu, E.,etc.Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double- blind, placebo-controlled trial[J].2015,74(9).
[12]Wenham, C. Y.,Hensor, E. M.,Grainger, A. J.,etc.A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis[J].2012,51(12).
[13]Praveen D,Rujaswini, T,Elancheziyan K.A PROSPECTIVE OBSERVATIONAL STUDY ON SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AGAINST DICLOFENAC IN OSTEOARTHRITIS[J].2019,11.
[14]Amit, Sood,Richa, Sood,Brent A, Bauer,etc.Cochrane systematic reviews in acupuncture: methodological diversity in database searching.[J].2005,11(4).
[15]Pap T,Frank S,Bertrand J,etc.Molecular mechanisms of cartilage remodelling in osteoarthritis.[J].2010,42(10).
[16]L R, Bryant,K F, des Rosier,M T, Carpenter.Hydroxychloroquine in the treatment of erosive osteoarthritis.[J].1995,22(8).
[17]Assirelli, Elisa,Pulsatelli, Lia,Dolzani, Paolo,etc.Human Osteoarthritic Cartilage Shows Reduced In Vivo Expression of IL-4, a Chondroprotective Cytokine that Differentially Modulates IL-1β-Stimulated Production of Chemokines and Matrix-Degrading Enzymes In Vitro.[J].2014,9(5).
[18]Roman-Blas, Jorge A,Castañeda, Santos,Largo, Raquel,etc.Osteoarthritis associated with estrogen deficiency[J].2009,11.
[19]Carsons, Steven E.,Vivino, Frederick B.,Parke, Ann,etc.Treatment Guidelines for Rheumatologic Manifestations of Sjogren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain[J].2017,69(4).
[20]David M, Findlay,Julia S, Kuliwaba.Bone-cartilage crosstalk: a conversation for understanding osteoarthritis.[J].2016.
[21]Yusuf E,Kortekaas MC,Watt I,etc.Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review.[J].2011,70(1).
[22]David J,Hunter,Sita,Bierma-Zeinstra.Osteoarthritis.[J].2019,393(10182).
[23]Choi JH,Jue DM,Byun MS,etc.Chloroquine inhibits production of TNF-{alpha}, IL-1{beta} and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.[J].2006,45(6).
[24]Lawrence JT,Birmingham J,Toth AP.Emerging ideas: prevention of posttraumatic arthritis through interleukin-1 and tumor necrosis factor-alpha inhibition.[J].2011,469(12).
[25]Fahmi H,Martel Pelletier J,Kapoor M,etc.Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.[J].2011,7(1).
[26]Towheed TE.Systematic review of therapies for osteoarthritis of the hand.[J].2005,13(6).
[27]Lee Weiching,Ruijgrok Liesbeth,Boxma‐de Klerk Bianca,etc.Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial[J].2018,70(9).
[28]Kulkarni, Kunal,Karssiens, Timothy,Kumar, Vijay,etc.Obesity and osteoarthritis[J].2016,89.
[29]Petri M.Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis[J].1996,5(1_suppl).
[30]Issa SN,Sharma L.Epidemiology of osteoarthritis: an update.[J].2006,8(1).
[31]Messina Osvaldo Daniel,Vidal Wilman Maritza,Vidal Neira Luis F..Nutrition, osteoarthritis and cartilage metabolism[J].2019,31(6).
[32].Avaliação do uso da hidroxicloroquina no tratamento da osteoartrite sintomática de joelhos Assessment of the use of hydroxychloroquine on knees' osteoarthritis treatment[J].2008.
[33]Diego, Kyburz,Fabia, Brentano,Steffen, Gay.Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling.[J].2006,2(9).
[34]Y. Yazici,T.E. McAlindon,R. Fleischmann,etc.A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study[J].2017,25(10).
[35]R, Altman,E, Asch,D, Bloch,etc.Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.[J].1986,29(8).
[36]Jokar, Mohammadhassan,Mirfeizi, Zahra,Keyvanpajouh, Kamran.The Effect of Hydroxychloroquine on Symptoms of Knee Osteoarthritis: A Double-Blind Randomized Controlled Clinical Trial.[J].2013,38(3).
[37]L, Punzi,N, Bertazzolo,M, Pianon,etc.Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis.[J].1996,23(8).
[38]Kingsbury, Sarah R.,Tharmanathan, Puvan,Keding, Ada,etc.Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis A Randomized Trial[J].2018,168(6).
[39]R. Altman,G. Alarcón,D. Appelrouth,etc.The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip[J].1991,34(5).
[40]Lesiak A,Narbutt J,Sysa Jedrzejowska A,etc.Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.[J].2010,19(6).
[41]Apte, Suneel S..Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis[J].2016,473(Pt.1).
[42]Jeffrey N. Katz,Kaetlyn R. Arant,Richard F. Loeser.Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review[J].2021,325(6).
[43]Lim,Y.Z.,Wang,Y.,Wluka,A.E.,etc.Are biomechanical factors, meniscal pathology, and physical activity risk factors for bone marrow lesions at the knee? A systematic review[J].2013,43(2).
[44]Maryam Rahmati,Giovanna Nalesso,Ali Mobasheri,etc.Aging and osteoarthritis: Central role of the extracellular matrix[J].2017,40.